Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).Reportar como inadecuado



 Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).


Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474). - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).
This article is from International Journal of Oncology, volume 44.AbstractProteasome inhibitors have been proven to be effective anticancer compounds in many tumor models, including glioblastoma multiforme (GBM). In this study, we found that the proteasome inhibitor Velcade (PS-341-bortezomib) caused GBM cell death while simultaneously activating t

Autor: LIN, LEHANG; GAUT, DARIA; HU, KAISHUN; YAN, HAIYAN; YIN, DONG; KOEFFLER, H. PHILLIP

Fuente: https://archive.org/







Documentos relacionados